Discovery Chemistry
Integrated discovery chemistry providing comprehensive services to speed up the early-stage drug discovery process with unparalleled capabilities.
Research Chemistry Services (RCS) is a global leading chemistry platform delivering synthetic and
medicinal chemistry solutions to global pharma, biotech companies, research institues and non-profit foundations.
As an integrated small molecule drug discovery platform,
WuXi Chemistry RCS provides both FTE (Full-time Equivalent) and FFS (Fee-for-Service) to
expedite the drug discovery process with productivity, speed, flexibility, quality and reliability.
The field of KRAS research is at an undeniably exciting crossroads. Medicines on the market have proved the “undruggable” could be drugged. Combination trials are on the move, searching out regimens that effectively fight against acquired resistance. A wave of new options is on the horizon that will expand treatments over the next few years.
SHANGHAI, January 12, 2025 – WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industries, announced that it has joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner, underscoring the company’s enduring commitment to responsible business practices and supply chain resilience.
Library synthesis is the process of synthesizing a series of compounds and evaluating them for hits that have desirable therapeutic properties toward a given target. This approach allows project teams to undertake efficient and systematic screening of biological pathways or target classes, improving the success rate of drug discovery programs. Pharma companies are increasingly developing and applying innovative capabilities to make better molecules faster. Many enabling chemistries and technologies have been developed to improve the access to target molecules with expanded chemical diversity.
Get in touch with an expert.